ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

Impact of Ultralarge von Willebrand Factor (VWF) Multimers and Platelets in Cultured Endothelial Cells in Acute Immune-mediated Thrombotic Thrombocytopenic Purpura

C. Vendramin1, F. Patella2, C. Lupo1, D. Cutler2, M. Scully1,3

1University College London, Haemostasis Research Unit, London, United Kingdom, 2University College London, MRC Laboratory for Molecular Cell Biology, London, United Kingdom, 3University College London Hospitals NHS Foundation Trust, Haematology, London, United Kingdom

Abstract Number: PB1891

Meeting: ISTH 2020 Congress

Theme: Thrombotic Microangiopathies » ADAMTS13 and TTP

Background: In the absence of functional ADAMTS13, ultralarge VWF multimers and platelets lead to the formation of platelet-rich microthrombi within small arterioles inducing immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP). Under physiological conditions, VWF is secreted from endothelial cells as ultralarge multimers, and ADAMTS13 progressively reduces the size of these VWF multimers as they circulate in the blood.

Aims: We studied the impact of VWF in platelet-dependent primary haemostasis in reduced/absence ADAMTS13 activity under flow conditions in acute thrombocytopenic iTTP patients.

Methods: A shear flow-based assay with Human Umbilical Vein Endothelial Cells (HUVECs) was developed. After histamine stimulation of endothelial cells, plasma with the addition of platelets at a concentration of 0.5-1 x108/mL was perfused through gelatin coated µ-slides VI (Ibidi, Germany) at a constant wall shear stress of 2.5 dynes/cm2. Cells were then immune-labelled for VWF and CD41 after being fixed under flow with 4% formaldehyde. Platelet recruitment and VWF coverage were quantified.

Results: We investigated twenty acute iTTP presentation patients with severe deficiency (< 10%) of ADAMTS13 activity. Median presenting anti-ADAMTS13 antibodies levels was 67% (range, 2%-140%) and median presenting ADAMTS13 antigen levels was 3.0% (range, 0.7%-47.6%). Pre-treatment median levels of VWF antigen and VWF activity were respectively 1.71IU/mL (range, 0.72 IU/mL-3.16 IU/mL) and 0.84 IU/mL (range, 0.15 IU/mL-2.10 IU/mL). With the shear flow-based assay with HUVECs, significant increase of platelet recruitment (p< 0.0001) and VWF coverage (p=0.0035) were observed in patients compared to pool normal plasma. Significant increase in median string number was reported in patients (n=83, range 46-184) compared to pool normal plasma (n=38, range 20-66) (p< 0.0001). Reduced ADAMTS13 activity increased the percentage of the longest (>100µm) strings in patients (p=0.0011).

Conclusions: Investigation of the interaction between VWF and platelets on HUVECs under shear flow may help to understand the pathophysiological mechanism of iTTP and could contribute in disease severity evaluation.

To cite this abstract in AMA style:

Vendramin C, Patella F, Lupo C, Cutler D, Scully M. Impact of Ultralarge von Willebrand Factor (VWF) Multimers and Platelets in Cultured Endothelial Cells in Acute Immune-mediated Thrombotic Thrombocytopenic Purpura [abstract]. Res Pract Thromb Haemost. 2020; 4 (Suppl 1). https://abstracts.isth.org/abstract/impact-of-ultralarge-von-willebrand-factor-vwf-multimers-and-platelets-in-cultured-endothelial-cells-in-acute-immune-mediated-thrombotic-thrombocytopenic-purpura/. Accessed October 1, 2023.

« Back to ISTH 2020 Congress

ISTH Congress Abstracts - https://abstracts.isth.org/abstract/impact-of-ultralarge-von-willebrand-factor-vwf-multimers-and-platelets-in-cultured-endothelial-cells-in-acute-immune-mediated-thrombotic-thrombocytopenic-purpura/

Simple Search

Supported By:

Takeda logo

ISTH 2022 Congress site

Visit the official web site for the ISTH 2022 Virtual Congress »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley